New Delhi [India], July 6 (ANI): The Indian drug regulator has urged Pfizer twice in writing to apply for emergency use authorization for its COVID-19 vaccine so that the application is processed well in time but Pfizer has not applied for the license yet, said sources on Tuesday.
Mumbai (Maharashtra) [India], June 7 (ANI): Pfizer India on Monday announced that it has partnered with an NGO named Doctors For You to help create a 400 Oxygen Bed capacity at Delhi's Yamuna COVID Care Centre, from which 10 per cent would be reserved for pediatric patients.
New Delhi [India], May 27 (ANI): Pfizer on Wednesday said it continues to remain engaged with the Indian government towards making its coronavirus vaccine available for use in the government immunisation programme.
New Delhi [India], May 26 (ANI): US pharmaceutical giant Pfizer is likely to supply 50 million COVID-19 vaccines to India in 2021, albeit with a few conditions, sources told ANI on Wednesday.
New Delhi [India], December 6 (ANI): Pfizer India has become the first pharmaceutical firm to approach the Drugs Controller General of India (DCGI) seeking an emergency use authorisation for its Covid-19 vaccine in the country.